HUP0201549A3 - Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them - Google Patents

Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them

Info

Publication number
HUP0201549A3
HUP0201549A3 HU0201549A HUP0201549A HUP0201549A3 HU P0201549 A3 HUP0201549 A3 HU P0201549A3 HU 0201549 A HU0201549 A HU 0201549A HU P0201549 A HUP0201549 A HU P0201549A HU P0201549 A3 HUP0201549 A3 HU P0201549A3
Authority
HU
Hungary
Prior art keywords
salts
pharmaceutical compositions
compositions containing
acid derivative
quinolinecarboxylic acid
Prior art date
Application number
HU0201549A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of HUP0201549A2 publication Critical patent/HUP0201549A2/hu
Publication of HUP0201549A3 publication Critical patent/HUP0201549A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0201549A 1999-07-01 2000-06-22 Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them HUP0201549A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01

Publications (2)

Publication Number Publication Date
HUP0201549A2 HUP0201549A2 (en) 2002-08-28
HUP0201549A3 true HUP0201549A3 (en) 2003-11-28

Family

ID=16207019

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201549A HUP0201549A3 (en) 1999-07-01 2000-06-22 Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (1) US6858625B1 (pt)
EP (1) EP1193266B1 (pt)
JP (1) JP3477465B2 (pt)
KR (1) KR100628414B1 (pt)
CN (1) CN1157389C (pt)
AT (1) ATE248162T1 (pt)
AU (1) AU766014B2 (pt)
BR (1) BR0012192A (pt)
CA (1) CA2376760C (pt)
CZ (1) CZ302033B6 (pt)
DE (1) DE60004846T2 (pt)
DK (1) DK1193266T3 (pt)
ES (1) ES2206257T3 (pt)
HK (1) HK1047103B (pt)
HU (1) HUP0201549A3 (pt)
IL (2) IL147043A0 (pt)
MX (1) MXPA02000103A (pt)
NO (1) NO321803B1 (pt)
NZ (1) NZ516201A (pt)
PT (1) PT1193266E (pt)
RU (1) RU2236408C2 (pt)
SK (1) SK285814B6 (pt)
TW (1) TW576832B (pt)
WO (1) WO2001002390A1 (pt)
ZA (1) ZA200110357B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
ZA200704862B (en) * 2004-11-17 2008-12-31 Wakunaga Pharma Co Ltd Novel pyridonecarboxylic acid derivatives or salts thereof
DK2346855T3 (en) * 2008-09-24 2017-07-24 Melinta Therapeutics Inc PROCEDURE FOR PREPARING QUINOLONE COMPOSITIONS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177302C (no) 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
BR9407283A (pt) 1993-08-13 1996-10-01 Dong Wha Pharm Co Ltd Derivados do ácido carboxílico quinolônico e processo de preparação
PT911327E (pt) 1995-09-22 2002-05-31 Wakunaga Pharma Co Ltd Novos derivados do acido piridonocarboxilico ou seus sais e agente antibacteriano compreendendo os mesmos como o ingrediente activo
WO1997040036A1 (fr) * 1996-04-19 1997-10-30 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
US6136823A (en) * 1996-11-28 2000-10-24 Wakunaga Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
EP1193266A4 (en) 2002-08-14
HK1047103B (zh) 2005-04-08
BR0012192A (pt) 2002-06-18
IL147043A (en) 2007-07-04
CZ20014598A3 (cs) 2002-05-15
NO20016378D0 (no) 2001-12-27
WO2001002390A1 (fr) 2001-01-11
ATE248162T1 (de) 2003-09-15
CZ302033B6 (cs) 2010-09-08
NZ516201A (en) 2003-06-30
US6858625B1 (en) 2005-02-22
DE60004846D1 (de) 2003-10-02
MXPA02000103A (es) 2003-07-21
JP3477465B2 (ja) 2003-12-10
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
CN1358183A (zh) 2002-07-10
HUP0201549A2 (en) 2002-08-28
SK285814B6 (sk) 2007-08-02
KR100628414B1 (ko) 2006-09-26
PT1193266E (pt) 2003-12-31
CA2376760C (en) 2008-11-25
CN1157389C (zh) 2004-07-14
AU5567900A (en) 2001-01-22
ZA200110357B (en) 2002-12-18
DK1193266T3 (da) 2003-11-24
IL147043A0 (en) 2002-08-14
EP1193266A1 (en) 2002-04-03
NO321803B1 (no) 2006-07-03
TW576832B (en) 2004-02-21
DE60004846T2 (de) 2004-06-03
CA2376760A1 (en) 2001-01-11
SK19162001A3 (sk) 2002-06-04
AU766014B2 (en) 2003-10-09
ES2206257T3 (es) 2004-05-16
HK1047103A1 (en) 2003-02-07
EP1193266B1 (en) 2003-08-27
RU2236408C2 (ru) 2004-09-20

Similar Documents

Publication Publication Date Title
HUP0303810A3 (en) Carboxylic acid derivative and salt thereof and pharmaceutical compositions containing them
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
HUP0202254A3 (en) Amide substituted imidazoquinolines and pharmaceutical compositions containing them
HK1053638A1 (en) Derivatives of dicarboxylic acid having pharmaceutical properties
HUP0204283A3 (en) Piperidine quinolyl propyl derivatives, preparation method and pharmaceutical compositions containing same
HUP0105133A3 (en) Quinoline derivatives and quinazoline derivatives, pharmaceutical compositions containing them and their use
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
IL145732A0 (en) α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HK1041445A1 (en) Pharmaceutical compositions of erythropoietin
HUP0202788A3 (en) Indolyl-3-glyoxylic acid derivatives serving as antitumor agents and pharmaceutical compositions containing them
EP1311477A4 (en) NEW THIOCARBAMIDIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEM
HUP0202255A3 (en) Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them
HUP0201714A2 (en) Substituted heterocyclic compounds and pharmaceutical compositions containing them
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
AU6827800A (en) Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
HUP0301080A3 (en) Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
IL159084A0 (en) Tetrahydroisoquinoline carboxylic acid derivatives and pharmaceutical compositions containing the same
IL148725A0 (en) Aqueous pharmaceutical compositions containing circlesonide
IL148106A0 (en) Pharmaceutical compositions comprising 4-quinolones
HUP0201549A2 (en) Quinolinecarboxylic acid derivative or salts thereof and pharmaceutical compositions containing them
HUP0001061A3 (en) Naphthylsulfonic acid derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished